vs
Side-by-side financial comparison of Alset Inc. (AEI) and Ovid Therapeutics Inc. (OVID). Click either name above to swap in a different company.
Alset Inc. is the larger business by last-quarter revenue ($1.3M vs $718.0K, roughly 1.8× Ovid Therapeutics Inc.). On growth, Ovid Therapeutics Inc. posted the faster year-over-year revenue change (844.7% vs -85.4%). Over the past eight quarters, Ovid Therapeutics Inc.'s revenue compounded faster (120.3% CAGR vs -53.7%).
Alset Global GmbH is an Austrian technology and engineering company based in Graz that specialises in hydrogen-based clean mobility products. Alset Global is known for developing a Hybrid Hydrogen internal combustion engine that can run on either pure petrol, pure hydrogen or a combination of both. This technology offers a sustainable and clean alternative to petrol-based internal combustion engines. The technology has been developed to create an alternative technology to meet new emission ta...
AEI vs OVID — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | ||
|---|---|---|
| Revenue | $1.3M | $718.0K |
| Net Profit | — | — |
| Gross Margin | 35.2% | — |
| Operating Margin | — | — |
| Net Margin | — | — |
| Revenue YoY | -85.4% | 844.7% |
| Net Profit YoY | -1491.5% | 204.4% |
| EPS (diluted) | — | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.3M | $718.0K | ||
| Q3 25 | $998.8K | $132.0K | ||
| Q2 25 | $1.1M | $6.3M | ||
| Q1 25 | $1.1M | $130.0K | ||
| Q4 24 | $8.9M | $76.0K | ||
| Q3 24 | $5.0M | $173.0K | ||
| Q2 24 | $1.1M | $169.0K | ||
| Q1 24 | $6.1M | $148.0K |
| Q4 25 | — | — | ||
| Q3 25 | $1.5M | $-12.2M | ||
| Q2 25 | $-8.2M | $-4.7M | ||
| Q1 25 | $-8.3M | $-10.2M | ||
| Q4 24 | $2.3M | — | ||
| Q3 24 | $1.7M | $-14.0M | ||
| Q2 24 | $-1.2M | $8.5M | ||
| Q1 24 | $-6.8M | $-11.7M |
| Q4 25 | 35.2% | — | ||
| Q3 25 | 24.3% | — | ||
| Q2 25 | 23.3% | — | ||
| Q1 25 | 27.2% | — | ||
| Q4 24 | 51.4% | — | ||
| Q3 24 | 40.5% | — | ||
| Q2 24 | 26.4% | — | ||
| Q1 24 | 23.5% | — |
| Q4 25 | — | — | ||
| Q3 25 | -258.2% | -9487.1% | ||
| Q2 25 | -250.7% | -80.9% | ||
| Q1 25 | -368.1% | -9653.8% | ||
| Q4 24 | 21.5% | — | ||
| Q3 24 | -19.4% | -7645.1% | ||
| Q2 24 | -249.3% | -12140.2% | ||
| Q1 24 | -37.2% | -11768.2% |
| Q4 25 | — | — | ||
| Q3 25 | 151.4% | -9210.6% | ||
| Q2 25 | -748.1% | -74.7% | ||
| Q1 25 | -780.1% | -7873.1% | ||
| Q4 24 | 26.0% | — | ||
| Q3 24 | 34.6% | -8096.0% | ||
| Q2 24 | -109.9% | 5042.0% | ||
| Q1 24 | -111.2% | -7901.4% |
| Q4 25 | — | — | ||
| Q3 25 | $0.05 | — | ||
| Q2 25 | $-0.71 | — | ||
| Q1 25 | $-0.78 | — | ||
| Q4 24 | $0.24 | — | ||
| Q3 24 | $0.19 | $-0.20 | ||
| Q2 24 | $-0.13 | $0.12 | ||
| Q1 24 | $-0.73 | $-0.17 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $25.2M | $13.2M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $121.1M | $130.7M |
| Total Assets | $136.6M | $150.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $25.2M | $13.2M | ||
| Q3 25 | $25.5M | $20.6M | ||
| Q2 25 | $25.6M | $28.4M | ||
| Q1 25 | $25.2M | $21.1M | ||
| Q4 24 | $27.2M | $26.3M | ||
| Q3 24 | $16.7M | $15.0M | ||
| Q2 24 | $18.9M | $29.7M | ||
| Q1 24 | $23.7M | $30.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $116.5K | — | ||
| Q4 24 | $123.1K | — | ||
| Q3 24 | $137.9K | — | ||
| Q2 24 | $137.8K | — | ||
| Q1 24 | $145.8K | — |
| Q4 25 | $121.1M | $130.7M | ||
| Q3 25 | $155.7M | $44.7M | ||
| Q2 25 | $72.8M | $55.8M | ||
| Q1 25 | $76.4M | $59.3M | ||
| Q4 24 | $81.3M | $68.2M | ||
| Q3 24 | $84.2M | $76.3M | ||
| Q2 24 | $79.4M | $88.9M | ||
| Q1 24 | $81.7M | $78.3M |
| Q4 25 | $136.6M | $150.9M | ||
| Q3 25 | $169.1M | $63.8M | ||
| Q2 25 | $86.0M | $77.4M | ||
| Q1 25 | $90.5M | $81.7M | ||
| Q4 24 | $96.8M | $92.2M | ||
| Q3 24 | $98.8M | $102.7M | ||
| Q2 24 | $93.5M | $118.1M | ||
| Q1 24 | $96.7M | $131.6M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 0.00× | — | ||
| Q4 24 | 0.00× | — | ||
| Q3 24 | 0.00× | — | ||
| Q2 24 | 0.00× | — | ||
| Q1 24 | 0.00× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $-5.9M | $-38.3M |
| Free Cash FlowOCF − Capex | $-6.1M | — |
| FCF MarginFCF / Revenue | -467.7% | — |
| Capex IntensityCapex / Revenue | 13.4% | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-11.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-5.9M | $-38.3M | ||
| Q3 25 | $883.4K | $-12.9M | ||
| Q2 25 | $-2.6M | $-4.8M | ||
| Q1 25 | $-3.8M | $-10.3M | ||
| Q4 24 | $5.2M | $-56.0M | ||
| Q3 24 | $-2.9M | $-15.0M | ||
| Q2 24 | $-4.4M | $-14.3M | ||
| Q1 24 | $-1.5M | $-16.7M |
| Q4 25 | $-6.1M | — | ||
| Q3 25 | $822.4K | — | ||
| Q2 25 | $-2.7M | — | ||
| Q1 25 | $-3.8M | — | ||
| Q4 24 | $5.1M | $-56.0M | ||
| Q3 24 | $-2.9M | $-15.0M | ||
| Q2 24 | $-4.4M | $-14.3M | ||
| Q1 24 | $-1.5M | $-16.7M |
| Q4 25 | -467.7% | — | ||
| Q3 25 | 82.3% | — | ||
| Q2 25 | -245.9% | — | ||
| Q1 25 | -357.3% | — | ||
| Q4 24 | 56.5% | -73719.7% | ||
| Q3 24 | -58.2% | -8676.9% | ||
| Q2 24 | -392.3% | -8455.0% | ||
| Q1 24 | -24.8% | -11287.2% |
| Q4 25 | 13.4% | 0.0% | ||
| Q3 25 | 6.1% | 0.0% | ||
| Q2 25 | 7.6% | 0.0% | ||
| Q1 25 | 5.7% | 0.0% | ||
| Q4 24 | 1.1% | 93.4% | ||
| Q3 24 | 0.6% | 2.3% | ||
| Q2 24 | 3.0% | 20.1% | ||
| Q1 24 | 0.0% | 12.8% |
| Q4 25 | — | — | ||
| Q3 25 | 0.58× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 2.22× | — | ||
| Q3 24 | -1.66× | — | ||
| Q2 24 | — | -1.67× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.